PYXS

Pyxis Oncology, Inc.

PYXS · CIK 1782223 · Annual (10-K) · Last 4 years

Financial Trends

Revenue$16M
20212024
Net Income−$77M
20212024
Operating CF−$58M
20212024
Free Cash Flow−$58M
20212024

Income Statement

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕
Revenue$0.0B———
Cost of Revenue$0.0B———
Gross Profit————
R&D Expense$0.1B$0.0B$0.1B$0.1B
SG&A Expense————
Operating Income$-0.1B$-0.1B$-0.1B$-0.1B
Net Income$-0.1B$-0.1B$-0.1B$-0.1B
EPS (Basic)$-1.32$-1.85$-3.65—
EPS (Diluted)$-1.32$-1.85$-3.65—

Balance Sheet

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕
Total Assets$0.2B$0.2B$0.2B$0.3B
Current Assets$0.1B$0.1B$0.2B$0.3B
Cash & Equivalents$0.0B$0.0B$0.2B$0.3B
Total Liabilities$0.0B$0.0B$0.1B$0.0B
Current Liabilities$0.0B$0.0B$0.0B$0.0B
Stockholders' Equity$0.1B$0.1B$0.2B$0.3B

Cash Flow Statement

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕
Operating Cash Flow$-0.1B$-0.1B$-0.1B$-0.0B
Investing Cash Flow$0.0B$-0.1B$-0.0B$-0.0B
Capital Expenditures$0.0B$0.0B$0.0B$0.0B
Financing Cash Flow$0.1B$0.0B$0.0B$0.3B
← Companies